Cargando…
Performance of an interferon-γ release assay-based test for cell-mediated immunity to SARS-CoV-2
In search for immunological correlates of protection against acute coronavirus disease 2019 (COVID-19) there is a need for high through-put assays for cell-mediated immunity (CMI) to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We established an interferon-γ release assay...
Autores principales: | Fonseca Brito, Luís, Tödter, Silvia, Kottlau, Julian, Cermann, Kathrin, Spier, Anthea, Petersen, Elina, Schäfer, Ines, Twerenbold, Raphael, Aepfelbacher, Martin, Lütgehetmann, Marc, Stahl, Felix R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978494/ https://www.ncbi.nlm.nih.gov/pubmed/36875076 http://dx.doi.org/10.3389/fimmu.2023.1069968 |
Ejemplares similares
-
Diagnostic Utility of Interferon-γ Release Assay in Tuberculous Lymphadenitis
por: Ye, Susu, et al.
Publicado: (2017) -
Serial testing with an interferon-γ release assay in German healthcare workers
por: Schablon, Anja, et al.
Publicado: (2010) -
Analysis of Factors Lowering Sensitivity of Interferon-γ Release Assay for Tuberculosis
por: Hang, Nguyen Thi Le, et al.
Publicado: (2011) -
Serial testing with the interferon-γ release assay in Portuguese healthcare workers
por: Torres Costa, José, et al.
Publicado: (2010) -
Interferon-γ Release Assay Performance in Pediatric Tuberculosis Disease in California
por: Kay, Alexander, et al.
Publicado: (2017)